Create Medic Co., Ltd.
2026 Q2 Consolidated Financial Results
Revenue is expanding its overseas share, illustrating a balance between domestic market growth and overseas sales. The 2026 Q2 consolidated results disclose trends in revenue and profit, segment-wise movements, and cash flow and balance sheet status. Progress toward the medium-term plan and future overseas expansion strategies are also clarified.
Key Figures
- Revenue: 6,932百万円
- Cost of Revenue: 4,113百万円
- Operating Profit: 336百万円
AI要約
Section Heading
This fiscal report, as a consolidated results report, discloses trends in key indicators such as revenue, gross profit, and operating profit. It also presents segment-wise revenue composition, trends in cost of sales and selling, general and administrative expenses, and cash flow status. Highlights include overseas market expansion strategy and progress of the medium-term plan.
Section 2 Heading
As for outlook, the plan to balance higher overseas revenue share with stable growth in the domestic market is described. Based on the medium-term management plan, the document outlines capital allocation, investment plans, expansion of R&D and manufacturing capacity, and efforts to curb SG&A, aiming to balance financial soundness with growth potential.
Create Medic Co., Ltd.
Company overview · Stock price · Financial data · All IR
